Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroOne Medical Tech Q1 2024 GAAP EPS $(0.14), Inline, Sales $977.65K Beat $852.00K Estimate

Author: Benzinga Newsdesk | February 13, 2024 05:04pm
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company reported quarterly sales of $977.65 thousand which beat the analyst consensus estimate of $852.00 thousand by 14.75 percent. This is a 753.25 percent increase over sales of $114.58 thousand the same period last year.

Posted In: NMTC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist